Publikationen in Zusammenarbeit mit Forschern von Leiden University Medical Center (6)

2024

  1. Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer

    Thrombosis and Haemostasis, Vol. 124, Núm. 7, pp. 676-683

2023

  1. Risk factors for recurrence and major bleeding in patients with cancer-associated venous thromboembolism

    European Journal of Internal Medicine, Vol. 112, pp. 29-36

2022

  1. Recurrent venous thromboembolism and major bleeding in patients with localised, locally advanced or metastatic cancer: an analysis of the Caravaggio study

    European Journal of Cancer, Vol. 165, pp. 136-145

2021

  1. Effects of concomitant administration of anticancer agents and apixaban or dalteparin on recurrence and bleeding in patients with cancer-associated venous thromboembolism

    European Journal of Cancer, Vol. 148, pp. 371-381

2020

  1. Apixaban for the treatment of venous thromboembolism associated with cancer

    New England Journal of Medicine, Vol. 382, Núm. 17, pp. 1599-1607

2018

  1. Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

    Thrombosis and Haemostasis, Vol. 118, Núm. 9, pp. 1668-1678